MX362290B - Un proceso mejorado para la preparacion de (3r,4r)-(1-bencilo-4-me tilpiperidina-3-il)-metilamina. - Google Patents
Un proceso mejorado para la preparacion de (3r,4r)-(1-bencilo-4-me tilpiperidina-3-il)-metilamina.Info
- Publication number
- MX362290B MX362290B MX2015015432A MX2015015432A MX362290B MX 362290 B MX362290 B MX 362290B MX 2015015432 A MX2015015432 A MX 2015015432A MX 2015015432 A MX2015015432 A MX 2015015432A MX 362290 B MX362290 B MX 362290B
- Authority
- MX
- Mexico
- Prior art keywords
- benzyl
- methylamine
- methylpiperidin
- preparation
- methyl pyridine
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 6
- NVKDDQBZODSEIN-OCCSQVGLSA-N (3r,4r)-1-benzyl-n,4-dimethylpiperidin-3-amine Chemical compound C1C[C@@H](C)[C@@H](NC)CN1CC1=CC=CC=C1 NVKDDQBZODSEIN-OCCSQVGLSA-N 0.000 abstract 2
- BSBVJNUGGBQEPO-UHFFFAOYSA-N 1-benzyl-4-methylpiperidin-3-one Chemical compound C1C(=O)C(C)CCN1CC1=CC=CC=C1 BSBVJNUGGBQEPO-UHFFFAOYSA-N 0.000 abstract 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 abstract 2
- -1 benzyl halide Chemical class 0.000 abstract 2
- WRPYDRDMRXJIJA-UHFFFAOYSA-N n-(4-methylpyridin-3-yl)acetamide Chemical compound CC(=O)NC1=CN=CC=C1C WRPYDRDMRXJIJA-UHFFFAOYSA-N 0.000 abstract 2
- 230000002829 reductive effect Effects 0.000 abstract 2
- IBKMZYWDWWIWEL-UHFFFAOYSA-N 4-methylpyridin-3-amine Chemical compound CC1=CC=NC=C1N IBKMZYWDWWIWEL-UHFFFAOYSA-N 0.000 abstract 1
- 230000006181 N-acylation Effects 0.000 abstract 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 229910000033 sodium borohydride Inorganic materials 0.000 abstract 1
- 239000012279 sodium borohydride Substances 0.000 abstract 1
- 235000002906 tartaric acid Nutrition 0.000 abstract 1
- 239000011975 tartaric acid Substances 0.000 abstract 1
- VXUYXOFXAQZZMF-UHFFFAOYSA-N titanium(IV) isopropoxide Chemical compound CC(C)O[Ti](OC(C)C)(OC(C)C)OC(C)C VXUYXOFXAQZZMF-UHFFFAOYSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/02—Preparation by ring-closure or hydrogenation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/98—Nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
La presente invención se refiere a un proceso mejorado y eficiente para la preparación de (3R,4R)-(1-bencilo-4-metilo-piper idina-3-il)-metilamina que comprende: (a) N-acilación de 3-amino-4-metil piridina; (b) cuaternización de 3-acetilamino-4-metil piridina utilizando haluro de bencilo; (c) reducción parcial de 3-acetilamino- 4-metil piridina cuaternizada mediante borohidruro de sodio en metanol o agua; (d) hidrólisis del producto parcialmente reducido a 1-bencilo-4-metilpiperidina-3 -ona en presencia de ácido; (e) aminación reductora de 1-bencilo-4-metilpiperidina-3-ona utilizando metilamina metanólica en presencia de isopropóxido de titanio (IV) en metanol; (f) resolución de 1-bencilo-4-metilpiperidina-3-il)-metil amina utilizando ácido ditoluoil (L) tartárico para obtener (3R,4R-1-bencilo-4-metilpiperidina-3-il)-metilamina. La invención también se refiere a productos intermedios novedosos. (ver Formulas) en donde R, R' y X son como se describen en la descripción.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2014/066510 WO2015087201A1 (en) | 2013-12-09 | 2014-12-02 | An improved process for the preparation of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine |
IN3843MU2013 IN2013MU03843A (es) | 2013-12-09 | 2014-12-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015015432A MX2015015432A (es) | 2016-03-15 |
MX362290B true MX362290B (es) | 2019-01-10 |
Family
ID=53370688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015015432A MX362290B (es) | 2013-12-09 | 2014-12-02 | Un proceso mejorado para la preparacion de (3r,4r)-(1-bencilo-4-me tilpiperidina-3-il)-metilamina. |
Country Status (14)
Country | Link |
---|---|
US (4) | US9951012B2 (es) |
EP (2) | EP3539965B1 (es) |
JP (1) | JP6368794B2 (es) |
BR (1) | BR112015025543B1 (es) |
ES (2) | ES2720066T3 (es) |
HU (2) | HUE042911T2 (es) |
IN (1) | IN2013MU03843A (es) |
MX (1) | MX362290B (es) |
PL (2) | PL2994454T3 (es) |
PT (2) | PT2994454T (es) |
SI (2) | SI2994454T1 (es) |
TR (1) | TR201904767T4 (es) |
WO (1) | WO2015087201A1 (es) |
ZA (1) | ZA201506551B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015087201A1 (en) * | 2013-12-09 | 2015-06-18 | Unichem Laboratories Limited | An improved process for the preparation of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine |
CN108349977B (zh) | 2015-01-20 | 2021-05-25 | 无锡福祈制药有限公司 | Jak抑制剂 |
EA036058B1 (ru) | 2015-04-29 | 2020-09-21 | Уси Форчун Фармасьютикал Ко., Лтд | Ингибитор jak |
US10174056B2 (en) | 2015-05-29 | 2019-01-08 | Wuxi Fortune Pharmaceutical Co., Ltd | Substituted pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors |
CN105237463B (zh) * | 2015-10-09 | 2017-10-10 | 刘卫国 | 一种(3r,4r)‑(1‑苄基‑4‑甲基哌啶‑3‑基)甲胺‑l‑二对甲苯甲酰酒石酸盐的制备方法 |
CN105884781B (zh) * | 2016-04-18 | 2018-04-20 | 山东罗欣药业集团股份有限公司 | 一种枸橼酸托法替布的制备方法 |
EP3301087A1 (en) * | 2016-09-30 | 2018-04-04 | DPx Fine Chemicals Austria GmbH & Co KG | Process for preparing chiral amines |
CN107056681B (zh) * | 2017-03-30 | 2019-10-01 | 广州白云山光华制药股份有限公司 | 一种托法替布中间体的制备方法 |
CN110668995A (zh) * | 2018-07-03 | 2020-01-10 | 江苏海悦康医药科技有限公司 | 一种枸橼酸托法替布中间体及枸橼酸托法替布的制备方法 |
CN112645866B (zh) * | 2020-12-22 | 2024-03-22 | 浙江奥翔药业股份有限公司 | 1-苄基-4-甲基-5-烷氧基-1,2,3,6-四氢吡啶衍生物的合成及应用 |
CN114685515A (zh) * | 2022-03-15 | 2022-07-01 | 上海蓝乐鸟实业有限公司 | 一种托法替尼的制备方法 |
CN115872923B (zh) * | 2022-12-29 | 2023-04-28 | 成都泰和伟业生物科技有限公司 | 一种化合物及其制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06145144A (ja) | 1992-11-04 | 1994-05-24 | Ihara Chem Ind Co Ltd | 新規な3−アミノピリジン誘導体第4級アンモニウム塩及びこれを有効成分とする抗癌剤 |
JP4671079B2 (ja) * | 1999-07-05 | 2011-04-13 | 日本農薬株式会社 | フタラミド誘導体、その中間体及び農園芸用殺虫剤並びにその使用方法 |
KR100496940B1 (ko) * | 1999-10-20 | 2005-06-23 | 다나베 세이야꾸 가부시키가이샤 | αLβ2 개재된 세포 접착 억제제 |
AP1905A (en) | 1999-12-10 | 2008-10-20 | Pfizer Prod Inc | Pyrrolo[2,3-d] Pyrimidine Compounds. |
ATE430749T1 (de) | 2001-02-24 | 2009-05-15 | Boehringer Ingelheim Pharma | Xanthinderivate verwendung als arzneimittel sowie deren verfahren zur deren herstellung |
US7301023B2 (en) | 2001-05-31 | 2007-11-27 | Pfizer Inc. | Chiral salt resolution |
GT200200234A (es) * | 2001-12-06 | 2003-06-27 | Compuestos cristalinos novedosos | |
WO2006067446A1 (en) * | 2004-12-22 | 2006-06-29 | Astrazeneca Ab | Pyridine carboxamide derivatives for use as anticancer agents |
US8232394B2 (en) | 2005-07-29 | 2012-07-31 | Pfizer Inc. | Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis |
WO2008029237A2 (en) * | 2006-09-05 | 2008-03-13 | Pfizer Products Inc. | Combination therapies for rheumatoid arthritis |
MX2011001259A (es) * | 2008-08-01 | 2011-03-15 | Biocryst Pharm Inc | Derivados de piperidina como inhibidores jak3. |
US20120034250A1 (en) | 2009-04-14 | 2012-02-09 | Astellas Pharma Inc. | Condensed pyrrolopyridine derivative |
BRPI1007737A2 (pt) * | 2009-04-20 | 2015-09-01 | Auspex Pharmaceuticals Llc | "composto da fórmula estrutural i, composição farmacêutica, método de tratamento de um distúbio mediano por janus quinase 3, método de preparação de um composto da fórmula estrutural ii, e método de preparação de um composto da fórmula estrutural xii" |
US20120225862A1 (en) * | 2009-07-21 | 2012-09-06 | Auckland Univservices Limited | Heteroaryl benzamides, compositions and methods of use |
CA2775753A1 (en) * | 2009-09-29 | 2011-04-07 | Paula Louise Nichols | Lrrk2 kinase inhibitors |
WO2015087201A1 (en) * | 2013-12-09 | 2015-06-18 | Unichem Laboratories Limited | An improved process for the preparation of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine |
-
2014
- 2014-12-02 WO PCT/IB2014/066510 patent/WO2015087201A1/en active Application Filing
- 2014-12-02 HU HUE14869304A patent/HUE042911T2/hu unknown
- 2014-12-02 EP EP19150972.8A patent/EP3539965B1/en active Active
- 2014-12-02 PT PT14869304T patent/PT2994454T/pt unknown
- 2014-12-02 SI SI201431159T patent/SI2994454T1/sl unknown
- 2014-12-02 MX MX2015015432A patent/MX362290B/es active IP Right Grant
- 2014-12-02 PL PL14869304T patent/PL2994454T3/pl unknown
- 2014-12-02 ES ES14869304T patent/ES2720066T3/es active Active
- 2014-12-02 HU HUE19150972A patent/HUE053975T2/hu unknown
- 2014-12-02 BR BR112015025543-4A patent/BR112015025543B1/pt not_active IP Right Cessation
- 2014-12-02 PL PL19150972T patent/PL3539965T3/pl unknown
- 2014-12-02 US US14/891,028 patent/US9951012B2/en active Active
- 2014-12-02 SI SI201431805T patent/SI3539965T1/sl unknown
- 2014-12-02 PT PT191509728T patent/PT3539965T/pt unknown
- 2014-12-02 JP JP2016557204A patent/JP6368794B2/ja not_active Expired - Fee Related
- 2014-12-02 IN IN3843MU2013 patent/IN2013MU03843A/en unknown
- 2014-12-02 TR TR2019/04767T patent/TR201904767T4/tr unknown
- 2014-12-02 ES ES19150972T patent/ES2865058T3/es active Active
- 2014-12-02 EP EP14869304.7A patent/EP2994454B1/en active Active
-
2015
- 2015-09-04 ZA ZA2015/06551A patent/ZA201506551B/en unknown
-
2017
- 2017-05-09 US US15/590,408 patent/US20170240510A1/en not_active Abandoned
- 2017-10-17 US US15/786,195 patent/US20180037551A1/en not_active Abandoned
-
2018
- 2018-01-11 US US15/868,331 patent/US10829450B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
HUE042911T2 (hu) | 2019-07-29 |
SI3539965T1 (sl) | 2021-07-30 |
US9951012B2 (en) | 2018-04-24 |
BR112015025543A2 (pt) | 2017-07-18 |
JP2017503007A (ja) | 2017-01-26 |
MX2015015432A (es) | 2016-03-15 |
WO2015087201A1 (en) | 2015-06-18 |
EP3539965B1 (en) | 2021-01-20 |
US20170240510A1 (en) | 2017-08-24 |
PL3539965T3 (pl) | 2021-07-05 |
HUE053975T2 (hu) | 2021-08-30 |
ES2720066T3 (es) | 2019-07-17 |
EP2994454B1 (en) | 2019-03-06 |
TR201904767T4 (tr) | 2019-05-21 |
US20180134661A1 (en) | 2018-05-17 |
PL2994454T3 (pl) | 2019-09-30 |
ES2865058T3 (es) | 2021-10-14 |
EP2994454A1 (en) | 2016-03-16 |
PT3539965T (pt) | 2021-04-07 |
ZA201506551B (en) | 2017-02-22 |
US20160102057A1 (en) | 2016-04-14 |
PT2994454T (pt) | 2019-04-02 |
EP2994454A4 (en) | 2016-12-21 |
EP3539965A1 (en) | 2019-09-18 |
SI2994454T1 (sl) | 2019-05-31 |
US20180037551A1 (en) | 2018-02-08 |
US10829450B2 (en) | 2020-11-10 |
IN2013MU03843A (es) | 2015-08-14 |
BR112015025543B1 (pt) | 2020-11-03 |
JP6368794B2 (ja) | 2018-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2015015432A (es) | Un proceso mejorado para la preparacion de (3r,4r)-(1-bencilo-4-me tilpiperidina-3-il)-metilamina. | |
MY170036A (en) | Process for the regioselective preparation of 1-alky1-3-haloalkylpyrazole-4-carboxylic acid derivatives | |
MY201120A (en) | Intermediates for use in a process of producing pyrrole compounds | |
MX2010009003A (es) | Ciclohexanodimetanamina por aminacion directa de ciclohexanodimetanol. | |
MX2011009369A (es) | 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3. | |
MX2011008262A (es) | Espiroamidas sustituidas como moduladores de b1r:. | |
MY155478A (en) | Process for the regioselective preparation of 1-alkyl-3-haloalkylpyrazole-4-carboxylic acid derivatives | |
MY163339A (en) | A method of producing ingenol-3-angelate | |
CL2009000503A1 (es) | Proceso de preparacion de compuestos derivados de acido 2-amino-5-cianobenzoico-3-sustituidos o 1h-pirazol-5-carboxamida. | |
EP2548949A4 (en) | MICROORGANISM WITH IMPROVED PRODUCTION OF 5'-XANTHOSINE MONOPHOSPHATE AND 5'-GUANINE MONOPHOSPHATE AND PRODUCTION PROCESS FOR 5'-XANTHOSINE MONOPHOSPHATE AND 5'-GUANINE MONOPHOSPHATE THEREWITH | |
EP2669252A4 (en) | METHOD FOR PRODUCING A HISTORIZED ANION EXCHANGE DOUBLE HYDROXIDE AND METHOD FOR REPLACING CARBONATE IONES OF A SHAPED DOUBLE HYDROXIDE WITH CARBONATE IONES | |
IN2015KN00323A (es) | ||
EP2609036A4 (en) | IMPROVING THE BRIGHTNESS OF A KALKET PRODUCT BY PRE-DELETING | |
WO2013121436A3 (en) | A process for preparation of rivaroxaban and intermediates thereof | |
MX2011008825A (es) | 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3. | |
EP2388261A3 (en) | Improved process for the preparation of carbapenem using carbapenem intermediates and recovery of carbapenem | |
UA112331C2 (uk) | Композиція, що містить блок-співконденсати пропіл-функціоналізованих силіконатів і силікатів лужних металів, а також спосіб їх одержання | |
PT2462098E (pt) | Processos para a preparação de derivados de ácido 1-(2- halobifenil-4-il)-ciclopropanocarboxílico | |
MX2011008662A (es) | 2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3. | |
MX2011009338A (es) | 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3. | |
EA201171466A1 (ru) | Композиция неслеживающейся соли, способ ее получения и использование | |
EA201000129A1 (ru) | Способ диафрагмализа и применение полученных этим способом продуктов | |
UA109269C2 (uk) | Незлежувана композиція хлориду калію, спосіб її отримання і застосування | |
MX337357B (es) | Excipiente para tableteado a base de lactosa y celulosa. | |
UA106724C2 (uk) | Спосіб отримання заміщених піримідинових похідних |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HH | Correction or change in general | ||
FG | Grant or registration |